Growth Metrics

Boston Scientific (BSX) Long-Term Deferred Tax (2016 - 2026)

Boston Scientific's Long-Term Deferred Tax history spans 18 years, with the latest figure at $4.0 billion for Q1 2026.

  • On a quarterly basis, Long-Term Deferred Tax rose 7.54% to $4.0 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $4.0 billion, a 7.54% increase, with the full-year FY2025 number at $3.7 billion, up 0.55% from a year prior.
  • Long-Term Deferred Tax hit $4.0 billion in Q1 2026 for Boston Scientific, up from $3.7 billion in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for BSX hit a ceiling of $4.1 billion in Q1 2022 and a floor of $3.7 billion in Q4 2024.
  • Historically, Long-Term Deferred Tax has averaged $3.8 billion across 5 years, with a median of $3.8 billion in 2023.
  • Biggest five-year swings in Long-Term Deferred Tax: decreased 4.92% in 2023 and later grew 7.54% in 2026.
  • Tracing BSX's Long-Term Deferred Tax over 5 years: stood at $3.9 billion in 2022, then decreased by 2.56% to $3.8 billion in 2023, then decreased by 4.84% to $3.7 billion in 2024, then grew by 0.55% to $3.7 billion in 2025, then increased by 7.56% to $4.0 billion in 2026.
  • Business Quant data shows Long-Term Deferred Tax for BSX at $4.0 billion in Q1 2026, $3.7 billion in Q4 2025, and $3.7 billion in Q3 2025.